During the evaluation of this active substance, concerns were identified. Those concerns were, in particular, the following. It was not possible to finalise the consumer risk assessment because consumer exposure could not be assessed reliably, in particular, with respect to magnitude and toxicological relevance of different metabolites. Furthermore, flufenoxuron has a high potential for bioaccumulation in the food chain. In addition, a high risk to aquatic organisms was identified.
Recital 7, Commission Implementing Regulation (EU) No 942/2011 of 22 September 2011 concerning the…
In forcesince 22 Sep 2011